S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
Log in

OTCMKTS:RCDTF - Recordati Stock Price, Forecast & News

$40.40
0.00 (0.00 %)
(As of 12/17/2019)
Today's Range
$40.40
Now: $40.40
$40.40
50-Day Range
$40.40
MA: $40.40
$40.40
52-Week Range
$40.40
Now: $40.40
$41.31
Volume622 shs
Average VolumeN/A
Market Capitalization$8.45 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.13
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals in Europe, the Middle East, Africa, the United States, Canada, and internationally. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, cosmetics, dermatology, dietary supplements, gynecology and obstetrics, medical devices, musculo-skeletal disorders and analgesia, over the counter/non-prescription pharmaceuticals, urology, allergy, anti-infectives, central nervous system, endocrinology, gastrointestinal, nutrition and related products, immune-suppressants, pain management/inflammation, generics, pneumology, antipyretics and cold preparations, endocrinology, oncology, respiratory, and radio contrast agent, as well as ear, nose, and throat. It also provides pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy.

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:RCDTF
Previous SymbolNASDAQ:RCDTF
CUSIPN/A
CIKN/A
Phone390-248-7871

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.60 billion
Cash Flow$2.09 per share
Book Value$5.44 per share

Profitability

Miscellaneous

Employees4,142
Market Cap$8.45 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive RCDTF News and Ratings via Email

Sign-up to receive the latest news and ratings for RCDTF and its competitors with MarketBeat's FREE daily newsletter.


Recordati (OTCMKTS:RCDTF) Frequently Asked Questions

What is Recordati's stock symbol?

Recordati trades on the OTCMKTS under the ticker symbol "RCDTF."

Has Recordati been receiving favorable news coverage?

Media headlines about RCDTF stock have trended somewhat positive recently, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Recordati earned a news sentiment score of 1.0 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 3.0 out of 10, meaning that recent news coverage is unlikely to have an effect on the company's share price in the near future. View News Stories for Recordati.

Who are some of Recordati's key competitors?

What other stocks do shareholders of Recordati own?

Who are Recordati's key executives?

Recordati's management team includes the folowing people:
  • Mr. Andrea Recordati, CEO & Director (Age 48)
  • Mr. Fritz Squindo, CFO, MD & Exec. Director (Age 63)
  • Ms. Marianne Tatschke, Director of Investor Relations & Corp. Communications
  • Ms. Daria Ghidoni, Director of Legal Affairs & Group Companies
  • Mr. Gabriele Finzi, VP & Director Corp. Devel.

How do I buy shares of Recordati?

Shares of RCDTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Recordati's stock price today?

One share of RCDTF stock can currently be purchased for approximately $40.40.

How big of a company is Recordati?

Recordati has a market capitalization of $8.45 billion and generates $1.60 billion in revenue each year. Recordati employs 4,142 workers across the globe.View Additional Information About Recordati.

What is Recordati's official website?

The official website for Recordati is http://www.recordati.com/.

How can I contact Recordati?

Recordati's mailing address is Via Matteo Civitali 1, Milano L6, 20148. The company can be reached via phone at 390-248-7871 or via email at [email protected]


MarketBeat Community Rating for Recordati (OTCMKTS RCDTF)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  80 (Vote Outperform)
Underperform Votes:  91 (Vote Underperform)
Total Votes:  171
MarketBeat's community ratings are surveys of what our community members think about Recordati and other stocks. Vote "Outperform" if you believe RCDTF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RCDTF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel